| Miss Lisa M Bilella, CRNA, APN | |
|
150 Bergen St, Newark, NJ 07103-2496 | |
| (973) 972-4200 | |
| Not Available |
| Full Name | Miss Lisa M Bilella |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407213325 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Lisa M Bilella, CRNA, APN 3850 Ridge Pike, House 2, Collegeville, PA 19426-3122 Ph: (718) 619-2036 | Miss Lisa M Bilella, CRNA, APN 150 Bergen St, Newark, NJ 07103-2496 Ph: (973) 972-4200 |
News Archive
Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
In an examination comparing the effects of two drugs on blood pressure, pulse, heart rate and cardiac output in women having elective delivery by cesarean section, an old assumption that uterine blood is redistributed into the maternal circulation after delivery was challenged, according to a study in the September issue of Anesthesiology.
Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist Injection, a macrocyclic gadolinium-based contrast agent, for intravenous use in diagnostic magnetic resonance imaging in adults and children to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system.
Micromet, Inc. today announced that its licensee for MT111, MedImmune, plans to initiate a Phase 1 trial in patients with advanced gastrointestinal cancers based on an investigational new drug (IND) application recently accepted by the U.S. Food and Drug Administration (FDA).
Oral cancer is more likely to spread in patients experiencing high levels of pain, according to a team of researchers at New York University College of Dentistry that found genetic and cellular clues as to why metastatic oral cancers are so painful.
› Verified 9 days ago
Mrs. Ariane Monique Chua Dequina, MSN, RN, NP-C, CMSRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 340 Airis Drive, Newark, NJ 07114 Phone: 973-877-0991 | |
Dr. Nancy S Redeker, PH.D., R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St Rm 1122, Umdnj School Of Nursing, Newark, NJ 07107 Phone: 973-972-3875 Fax: 973-972-7853 | |
Paul V Scott, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5043 | |
Miriam Salami, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 687 S 17th St, Fl 1, Newark, NJ 07103 Phone: 973-444-5487 | |
Ms. Jessica Hampson, RN, RNFA, CNOR Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 | |
Vasley St.juste, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 75 Sandford Pl, Newark, NJ 07106 Phone: 973-288-3474 | |
Mr. Eduardo Jamisola Padilla Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 515 Mount Prospect Ave Apt 17b, Newark, NJ 07104 Phone: 201-724-5582 |